Shorla Oncology

Shorla Announces Partnership with EVERSANA to Support the Launch and Commercialization of T-cell Leukemia Treatment.

Cambridge, Massachusetts, USA.  17 August, 2021.  Seroba’s portfolio company, Shorla Pharma (‘Shorla’), a specialty pharmaceutical company and EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today announced a partnership to support the launch and commercialization of Shorla’s oncology portfolio.  The new partnership will initially focus on SH-111, an oncology […]

Shorla Announces Partnership with EVERSANA to Support the Launch and Commercialization of T-cell Leukemia Treatment. Read More »